£2.5M
The biotechnology funding pairs strategic capital with a collaborative agreement to explore oncology opportunities.
AD
AMPLY Discovery
AMPLY Discovery develops therapeutic programmes using artificial intelligence and experimental testing.
£4.7MTotal raised
AMPLY Discovery is an artificial intelligence driven drug discovery company based in the United Kingdom. The firm leverages multi-omic datasets and laboratory testing to generate therapeutic programmes for partnering.
Filed accounts
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from AMPLY Discovery's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
DT
Dermot Tierney
Co-Founder and Chief Operating Officer
Dermot is co-founder and chief operating officer at AMPLY Discovery. He previously managed intellectual property and commercialisation at Queen's University Belfast.
LinkedInInvestors
- £2.5M
- £1.3M
- £900K
Funding history
£1.3M
Twin Path Ventures led the seed financing for the Belfast biotechnology firm to accelerate its preclinical discovery programmes.
£900K
The Belfast biotechnology company raised the capital from investors including Co-fund NI, QUBIS, and the Halo Business Angel Network.